SB 248: Strengthening Utah’s Psychotherapeutic Therapy Pilot Program
This bill ensures that Utah’s medicinal psilocybin and MDMA pilot program can move forward by allowing qualified healthcare providers to participate after the initial healthcare systems declined to do so.
Transforming Treatment: Psilocybin’s Role in Mental Health
Utah needs to move forward with a medicinal psilocybin therapy program instead of waiting for FDA approval
HB 68: Mandatory Prison for Drug Distribution with a Firearm
This bill makes prison mandatory for people who share drugs (including cannabis, psilocybin, etc.) while possessing a firearm.
SB 200: Medicinal Psilocybin Program for Utahns
This bill offers Utahns a way to safely access psilocybin for medical use.
A Framework for Patients to Safely Access Psychotherapeutic Medicine in Utah
Following months of study, the Utah Mental Illness and Psychotherapy Task Force found that MDMA and psilocybin (“magic mushrooms”) can offer significant benefits to those with mental illness.
How Safe Are Psychotherapeutics?
Drug policy, like all policy, should be based on facts. In this case, the facts show that psychotherapeutics are safer and less harmful than alcohol and not deserving of their Schedule I classification.